It is administered as a once-weekly subcutaneous injection with a defined dose-titration schedule
12 weeks: 5 vials use 10 mL total
Based on your detailed feedback, we may suggest: Splitting the full dose into two smaller injections spaced apart
There is no published long-term off-drug follow-up for cagrilintide monotherapy (phase 2 only tracked 6 weeks post-treatment), but every drug in this class shows partial weight regain after stopping, and the REDEFINE 1 authors state outright that long-term treatment will probably be required to sustain the benefit
This article presents a comprehensive overview of GHK-Cu injections: its biological mechanisms , reported benefits, and clinical applications
Much of what is sold online is labeled research only, and the purity of those products is highly variable, with independent testing repeatedly finding under-dosed, degraded, or mislabeled peptides across the unregulated market